Somerville, MA, United States of America

Richard Heidebrecht

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Richard Heidebrecht: Innovator in Biocompatible Hydrogel Technology

Introduction

Richard Heidebrecht is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of biocompatible materials, holding a total of 3 patents. His work focuses on innovative solutions that enhance the quality and functionality of hydrogel capsules and implantable particles.

Latest Patents

Heidebrecht's latest patents include "Biocompatible hydrogel capsules and process for preparing same." This patent describes compositions and methods for preparing hydrogel capsules using a cross-linking solution that includes a process additive. The process additive is designed to improve the quality of the resulting hydrogel capsules, notably increasing the number of defect-free capsules. Another significant patent is "Implantable particles and related methods," which details particles that consist of a first compartment, a second compartment, and a compound of Formula (I). These particles may include a cell capable of expressing a therapeutic agent useful for treating various diseases, disorders, or conditions.

Career Highlights

Richard Heidebrecht is currently associated with Sigilon Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the creation of innovative therapeutic solutions that leverage biocompatible materials.

Collaborations

Heidebrecht collaborates with esteemed colleagues, including Robert James Miller and Omid Veiseh, who contribute to the innovative environment at Sigilon Therapeutics, Inc.

Conclusion

Richard Heidebrecht's contributions to biocompatible hydrogel technology and implantable particles underscore his role as a leading inventor in the field. His patents reflect a commitment to advancing medical technology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…